Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication

Virology

Volumn 385, Issue 2, 2009, Pages 464-472

  Rizvi, Tahir A ^a   Ali, Jahabar ^a   Phillip, Pretty Susan ^a   Ghazawi, Akela ^a   Jayanth, Preethi ^a   Mustafa, Farah ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Constitutive transport element (CTE); Human gene therapy; Mouse mammary tumor virus (MMTV); Regulation of gene expression; Retroviral vectors; RNA packaging

Indexed keywords

GAG PROTEIN; POL PROTEIN; RETROVIRUS VECTOR; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; MASON PFIZER MONKEY VIRUS; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRAL CONSTITUTIVE TRANSPORT ELEMENT; RNA TRANSCRIPTION; RNA TRANSPORT; VIRUS GENE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CELL LINE; FUSION PROTEINS, GAG-POL; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HELA CELLS; HUMANS; MAMMARY TUMOR VIRUS, MOUSE; PLASMIDS; RETROVIRIDAE; RNA, VIRAL; VIRUS ASSEMBLY; VIRUS REPLICATION;

BETARETROVIRUS; MASON-PFIZER MONKEY VIRUS; MOUSE MAMMARY TUMOR VIRUS;

EID: 60649118911     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.12.027     Document Type: Article

References (40)

1. Acha-Orbea H., and Palmer E. Mls-a retrovirus exploits the immune system. Immunol. Today 12 (1991) 356-361
2. Ahmed F., Wyckoff J., Lin E.Y., Wang W., Wang Y., Hennighausen L., Miyazaki J., Jones J., Pollard J.W., Condeelis J.S., and Segall J.E. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res. 62 (2002) 7166-7169
3. Andrechek E.R., Laing M.A., Girgis-Gabardo A.A., Siegel P.M., Cardiff R.D., and Muller W.J. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Res. 63 (2003) 4920-4926
4. Arroyo J., Winchester E., McLellan B.S., and Huber B.T. Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain. J. Virol. 71 (1997) 1237-1245
5. Bor Y.C., Swartz J., Morrison A., Rekosh D., Ladomery M., and Hammarskjöld M.L. The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron. Genes Dev. 20 (2006) 1597-1608
6. Bray M., Prasad S., Dubay J.W., Hunter E., Jeang K.T., Rekosh D., and Hammarskjold M.L. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. U.S.A. 4 (1994) 1256-1260
7. Browning M.T., Schmidt R.D., Lew K.A., and Rizvi T.A. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Virol. 75 (2001) 5129-5140
8. Butsch M., Hull S., Wang Y., Roberts T.M., and Boris-Lawrie K. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production. J. Virol. 73 (1999) 4847-4855
9. Coffin J.M. Structure and classification of retroviruses. In: Levy J.A. (Ed). The Retroviridae (1992), Plenum Press, New York 19-49
10. Dangerfield J.A., Hohenadl, Egerbacher M., Kodajova P., Salmons B., and Gunzberg W.H. HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression. Gene 358 (2005) 17-30
11. Darlix J.L. Circularization of retroviral genomic RNA and the control of RNA translation, packaging and reverse transcription. Biochimie 68 (1986) 941-949
12. D'Souza V., and Summers M.F. How retroviruses select their genomes. Nat. Rev., Microbiol. 8 (2005) 643-655
13. Felber B., Zolotukhin A.S., and Pavlakis G.N. Posttranscriptional control of HIV-1 and other retroviruses and its practical applications. Adv. Pharmacol. 55 (2007) 161-197
14. Ghazawi A., Mustafa F., Phillip P.S., Jayanth P., Ali J., and Rizvi T.A. Both the 5′ and 3′ LTRs of FIV contain minor RNA encapsidation determinants compared to the two core packaging determinants within the 5′ untranslated region and gag. Microbes Infect. 3 (2006) 767-778
15. Günzburg W.H., Heinemann F., Wintersperger S., Miethke T., Wagner H., Erfle V., and Salmons B. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364 (1993) 154-158
16. Ham J., Thomson A., Needham M., Webb P., and Parker M. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res. 16 (1988) 5263-5276
17. Indik S., Gunzburg W.H., Salmons B., and Rouault F. Mouse mammary tumor virus infects human cells. Cancer Res. 65 (2005) 6651-6659
18. Jin L., Guzik B.W., Bor Y.C., Rekosh D., and Hammarskjöld M.L. Tap and NXT promote translation of unspliced mRNA. Genes Dev. 17 (2003) 3075-3086
19. Klein R., Ruttkowski B., Schwab S., Peterbauer T., Salmons B., Günzburg W.H., and Hohenadl C. Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo. J. Biomed. Biotechnol. 2008 (2008) 683505
20. Lever A.M.L. HIV RNA packaging. Adv. Pharmacol. 55 (2007) 1-32
21. Marrack P., Kushnir E., and Kappler J. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349 (1991) 524-526
22. Marsh J.L., Erfle M., and Wykes E.J. The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene 2 (1984) 481-485
23. Meiering C.D., Rubio C., May C., and Linial M.L. Cell-types-specific regulation of the two foamy virus promoters. J. Virol. 75 (2001) 6547-6557
24. Mertz J.A., Simper M.S., Lozano M.M., Payne S.M., and Dudley J.P. Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus. J Virol. 79 (2005) 14737-14747
25. Miller C.L., Garner R., and Paetkau V. An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Mol. Cell. Biol. 12 (1992) 3262-3272
26. Müllner M., Salmons B., Günzburg W.H., and Indik S. Identification of the Rem-responsive element of mouse mammary tumor virus. Nucleic Acids Res. 36 (2008) 6284-6294
27. Mustafa F., Lozaon M., and Dudley J.P. C3H mouse mammary tumor virus superantigen function requires a splice donor in the envelope gene. J. Virol. 74 (2000) 9431-9440
28. Mustafa F., Bhadra S., Johnston D., Lozano M., and Dudley J.P. The type B leukemogenic virus superantigen is dispensable for T-cell lymphomagenesis. J. Virol. 77 (2003) 3866-3870
29. Mustafa F., Jayanth P., Phillip P.S., Ghazawi A., Schmidt R.D., Lew K.A., and Rizvi T.A. Relative activity of the feline immunodeficiency virus promoter in feline and primate cell lines. Microbes Infect. 7 (2005) 233-239
30. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272 (1996) 263-267
31. Rizvi T.A., and Panganiban A. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67 (1993) 2681-2688
32. Rizvi T.A., Schmidt R.D., Lew K.A., and Keeling M.E. Rev/RRE-independent Mason-Pfizer monkey virus-constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay. Virology 222 (1996) 457-463
33. Ross S.R., and Solter D. Glucocorticoid regulation of mouse mammary tumor virus sequences in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 5880-5884
34. Salmons B., Moritz-Legrand S., Garcha I., and Günzburg W.H. Construction and characterization of a packaging cell line for MMTV-based conditional retroviral vectors. Biochem. Biophys. Res. Comm. 159 (1989) 1191-1198
35. Salmons B., Erfle V., Brem G., and Günzburg W.H. Naf, a trans-regulating negative-cis acting factor encoded within the mouse mammary tumor virus open reading frame region. J. Virol. 64 (1990) 6355-6359
36. Shackleford G.M., and Varmus H.E. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9655-9659
37. Stewart T.A., Pattengale P.K., and Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38 (1984) 627-637
38. Swartz J.E., Bor Y.C., Misawa Y., Rekosh D., and Hammarskjold M.L. The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element. J. Biol. Chem. 282 (2007) 19844-19853
39. Tan W., Felber B.K., Zolotukhin A.S., Pavlakis G.N., and Schwartz S. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69 (1995) 5607-5620
40. Wagner K.U., Wall R.J., St-Onge L., Gruss P., Wynshaw-Boris A., Garrett L., Li M., Furth P.A., and Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25 (1997) 4323-4330